Creating mini-brains from stem cells reveals a new, promising treatment for a devastating childhood disease

Variants in the DHDDS gene cause a severe neurodegenerative condition, characterized by tremors, seizures, coordination and learning difficulties, usually manifesting in early childhood. This Parkinson's-like condition is extremely rare, and until recently, parents were told there was nothing that could be done to slow its progression. But now, researchers from the Netherlands and the U.S. who created "mini brain" models from patients' own cells to test new therapies have found not only the mechanism of the disease, but also that a naturally occurring form of vitamin B3 (nicotinamide mononucleotide, or NMN) holds significant promise in slowing disease progression.

Integrating genetic origin data with tumor analyses enables better prediction of survival

New research to be presented today at the annual conference of the European Society of Human Genetics shows that a cancer patient's genetic ancestry can have a significant effect both on how their disease progresses and their survival. In the largest study of its kind, researchers examined nearly 1,900 specific genetic changes in tumors to measure whether certain mutations were more common in patients with different historic geographic origins.

The press is breaking the suicide taboo but still uses stigmatizing metaphors

Suicide is a major public health concern. According to the World Health Organization (WHO), it is responsible for more than 700,000 deaths a year. In Spain, it is the leading cause of death from non-natural causes, above traffic accidents. The number of suicides in recent years has reached record highs, especially since the COVID-19 pandemic. In 2022, 4,227 people (74% of them men and 26% women) died from this cause. In other words, an average of 12 people a day died by suicide.

Hidden switch lets two of four receptor subunits open brain ion channel

To transmit excitatory signals, nerve cells mostly use glutamate as a neurotransmitter. To detect these transmitter signals, the cells can rely on a whole repertoire of receptors with different signaling properties. Researchers at the Chair of Cellular Neurobiology, led by Professor Andreas Reiner at Ruhr University Bochum, Germany, together with collaboration partners in New York (Department of Biochemistry and Biophysics, Weill Cornell Medicine), investigated the function of a specific glutamate receptor complex and made some surprising observations. Their findings were reported in the journal Nature Communications on April 24, 2026.

Semaglutide linked to lower bone fracture risk

In people with type 2 diabetes, semaglutide was associated with a 15% reduction in bone fractures and greater weight loss compared with other anti-obesity medications, according to a study presented at ENDO 2026, the Endocrine Society's annual meeting in Chicago.

Boosting protein folding could protect insulin-making cells in diabetes

Origami masters turn simple sheets of paper into ornate sculptures. In the origami of life, our cells must fold proteins into specific three-dimensional shapes before they can carry out their biological jobs. This folding process goes awry as prediabetes progresses into diabetes. Misfolded and dysfunctional proteins then build up in cells like discarded wads of paper in an origami student's recycling bin. This abnormal accumulation stresses the cells responsible for producing insulin.